In addition, these differential genes had considerable overlap with those of CD8 T cells between CML and control samples, including 39.9% up-regulated genes and 32.5% down-regulated genes, which was the highest among all CD8 T cell subtypes. The gene discussed is CD8A; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.